ロード中...
Simultaneous blockade of IL-6 and CCL5 signaling for synergistic inhibition of triple-negative breast cancer growth and metastasis
BACKGROUND: Metastatic triple-negative breast cancer (TNBC) is a heterogeneous and incurable disease. Numerous studies have been conducted to seek molecular targets to treat TNBC effectively, but chemotherapy is still the main choice for patients with TNBC. We have previously presented evidence of t...
保存先:
| 出版年: | Breast Cancer Res |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6000947/ https://ncbi.nlm.nih.gov/pubmed/29898755 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13058-018-0981-3 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|